anti ccl2 Search Results


92
Miltenyi Biotec apc
Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ccl2/pmc10961001-250-7-10?v=Miltenyi+Biotec
Average 92 stars, based on 1 article reviews
apc - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

86
Thermo Fisher gene exp ccl2 ss03394377 m1
Gene Exp Ccl2 Ss03394377 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ccl2/pmc06736846__41598_2019_49502_MOESM1_ESM-2-111--1?v=Thermo+Fisher
Average 86 stars, based on 1 article reviews
gene exp ccl2 ss03394377 m1 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

86
Signalway Antibody ccl2 mcp 1
Ccl2 Mcp 1, supplied by Signalway Antibody, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ccl2/pm42249304-157-8-11?v=Signalway+Antibody
Average 86 stars, based on 1 article reviews
ccl2 mcp 1 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

95
Bio X Cell anti ccl2 antibody
( A ) Tumor samples from mice treated with vehicle or AP21967 at 9 weeks were homogenized, and the levels of the indicated cytokines were analyzed using a cytokine array. The log 2 FC (AP21967/vehicle) for each cytokine is presented. ENA-78, epithelial-derived neutrophil-activating peptide 78; GROα, growth-regulated oncogene-alpha. ( B ) Levels of <t>CCL2</t> and CXCL1 were quantified by ELISA from the same tumor homogenates as in (A). ( C ) UMAP plots showing the expression of the most up-regulated cytokines (CCL2, CCL3, and CCL7) and their receptors (CCR1, CCR2, and CCR5) in different cell populations. Relevant cell clusters are indicated. N, neutrophils; MØ, macrophages; E, endothelial cells; F, fibroblasts. ( D ) Flow cytometry analysis of myeloid cells purified from tumors obtained from SuSe mice treated with vehicle or AP21967. We identified TAMs and cells positive for the myeloid marker CD11B and for the macrophage marker F4/80. ( E ) The same cells as in (D) were cultured for 24 hours—in the presence of vehicle or anti-CCL2—and the presence of CCL2 in the conditioned medium was determined by ELISA. ( F ) Schematic representation of the specificities of receptors for CCL2, CCL3, and CCL7. ( G ) Flow cytometry analysis of CCR2 in the same cells as in (D). FSH-H, forward scatter height.
Anti Ccl2 Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ccl2/pmc12757032-191-13-16?v=Bio+X+Cell
Average 95 stars, based on 1 article reviews
anti ccl2 antibody - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

93
Boster Bio mcp 1
( A ) Tumor samples from mice treated with vehicle or AP21967 at 9 weeks were homogenized, and the levels of the indicated cytokines were analyzed using a cytokine array. The log 2 FC (AP21967/vehicle) for each cytokine is presented. ENA-78, epithelial-derived neutrophil-activating peptide 78; GROα, growth-regulated oncogene-alpha. ( B ) Levels of <t>CCL2</t> and CXCL1 were quantified by ELISA from the same tumor homogenates as in (A). ( C ) UMAP plots showing the expression of the most up-regulated cytokines (CCL2, CCL3, and CCL7) and their receptors (CCR1, CCR2, and CCR5) in different cell populations. Relevant cell clusters are indicated. N, neutrophils; MØ, macrophages; E, endothelial cells; F, fibroblasts. ( D ) Flow cytometry analysis of myeloid cells purified from tumors obtained from SuSe mice treated with vehicle or AP21967. We identified TAMs and cells positive for the myeloid marker CD11B and for the macrophage marker F4/80. ( E ) The same cells as in (D) were cultured for 24 hours—in the presence of vehicle or anti-CCL2—and the presence of CCL2 in the conditioned medium was determined by ELISA. ( F ) Schematic representation of the specificities of receptors for CCL2, CCL3, and CCL7. ( G ) Flow cytometry analysis of CCR2 in the same cells as in (D). FSH-H, forward scatter height.
Mcp 1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ccl2/pmc05378361-34-7-12?v=Boster+Bio
Average 93 stars, based on 1 article reviews
mcp 1 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

86
Servicebio Inc antibodies ccl 2
( A ) Tumor samples from mice treated with vehicle or AP21967 at 9 weeks were homogenized, and the levels of the indicated cytokines were analyzed using a cytokine array. The log 2 FC (AP21967/vehicle) for each cytokine is presented. ENA-78, epithelial-derived neutrophil-activating peptide 78; GROα, growth-regulated oncogene-alpha. ( B ) Levels of <t>CCL2</t> and CXCL1 were quantified by ELISA from the same tumor homogenates as in (A). ( C ) UMAP plots showing the expression of the most up-regulated cytokines (CCL2, CCL3, and CCL7) and their receptors (CCR1, CCR2, and CCR5) in different cell populations. Relevant cell clusters are indicated. N, neutrophils; MØ, macrophages; E, endothelial cells; F, fibroblasts. ( D ) Flow cytometry analysis of myeloid cells purified from tumors obtained from SuSe mice treated with vehicle or AP21967. We identified TAMs and cells positive for the myeloid marker CD11B and for the macrophage marker F4/80. ( E ) The same cells as in (D) were cultured for 24 hours—in the presence of vehicle or anti-CCL2—and the presence of CCL2 in the conditioned medium was determined by ELISA. ( F ) Schematic representation of the specificities of receptors for CCL2, CCL3, and CCL7. ( G ) Flow cytometry analysis of CCR2 in the same cells as in (D). FSH-H, forward scatter height.
Antibodies Ccl 2, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ccl2/pmc09608739-86-15-20?v=Servicebio+Inc
Average 86 stars, based on 1 article reviews
antibodies ccl 2 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

99
Thermo Fisher gene exp ccl2 mm00441242 m1
( A ) Tumor samples from mice treated with vehicle or AP21967 at 9 weeks were homogenized, and the levels of the indicated cytokines were analyzed using a cytokine array. The log 2 FC (AP21967/vehicle) for each cytokine is presented. ENA-78, epithelial-derived neutrophil-activating peptide 78; GROα, growth-regulated oncogene-alpha. ( B ) Levels of <t>CCL2</t> and CXCL1 were quantified by ELISA from the same tumor homogenates as in (A). ( C ) UMAP plots showing the expression of the most up-regulated cytokines (CCL2, CCL3, and CCL7) and their receptors (CCR1, CCR2, and CCR5) in different cell populations. Relevant cell clusters are indicated. N, neutrophils; MØ, macrophages; E, endothelial cells; F, fibroblasts. ( D ) Flow cytometry analysis of myeloid cells purified from tumors obtained from SuSe mice treated with vehicle or AP21967. We identified TAMs and cells positive for the myeloid marker CD11B and for the macrophage marker F4/80. ( E ) The same cells as in (D) were cultured for 24 hours—in the presence of vehicle or anti-CCL2—and the presence of CCL2 in the conditioned medium was determined by ELISA. ( F ) Schematic representation of the specificities of receptors for CCL2, CCL3, and CCL7. ( G ) Flow cytometry analysis of CCR2 in the same cells as in (D). FSH-H, forward scatter height.
Gene Exp Ccl2 Mm00441242 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ccl2/pmc11662124__40635_2024_707_MOESM3_ESM-0-68--1?v=Thermo+Fisher
Average 99 stars, based on 1 article reviews
gene exp ccl2 mm00441242 m1 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

90
Cusabio mouse monoclonal antibodies against mcp 1
( A ) Tumor samples from mice treated with vehicle or AP21967 at 9 weeks were homogenized, and the levels of the indicated cytokines were analyzed using a cytokine array. The log 2 FC (AP21967/vehicle) for each cytokine is presented. ENA-78, epithelial-derived neutrophil-activating peptide 78; GROα, growth-regulated oncogene-alpha. ( B ) Levels of <t>CCL2</t> and CXCL1 were quantified by ELISA from the same tumor homogenates as in (A). ( C ) UMAP plots showing the expression of the most up-regulated cytokines (CCL2, CCL3, and CCL7) and their receptors (CCR1, CCR2, and CCR5) in different cell populations. Relevant cell clusters are indicated. N, neutrophils; MØ, macrophages; E, endothelial cells; F, fibroblasts. ( D ) Flow cytometry analysis of myeloid cells purified from tumors obtained from SuSe mice treated with vehicle or AP21967. We identified TAMs and cells positive for the myeloid marker CD11B and for the macrophage marker F4/80. ( E ) The same cells as in (D) were cultured for 24 hours—in the presence of vehicle or anti-CCL2—and the presence of CCL2 in the conditioned medium was determined by ELISA. ( F ) Schematic representation of the specificities of receptors for CCL2, CCL3, and CCL7. ( G ) Flow cytometry analysis of CCR2 in the same cells as in (D). FSH-H, forward scatter height.
Mouse Monoclonal Antibodies Against Mcp 1, supplied by Cusabio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ccl2/ppr0402354-25-0-12?v=Cusabio
Average 90 stars, based on 1 article reviews
mouse monoclonal antibodies against mcp 1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

mcp 1  (Bioss)
94
Bioss mcp 1
( A ) Tumor samples from mice treated with vehicle or AP21967 at 9 weeks were homogenized, and the levels of the indicated cytokines were analyzed using a cytokine array. The log 2 FC (AP21967/vehicle) for each cytokine is presented. ENA-78, epithelial-derived neutrophil-activating peptide 78; GROα, growth-regulated oncogene-alpha. ( B ) Levels of <t>CCL2</t> and CXCL1 were quantified by ELISA from the same tumor homogenates as in (A). ( C ) UMAP plots showing the expression of the most up-regulated cytokines (CCL2, CCL3, and CCL7) and their receptors (CCR1, CCR2, and CCR5) in different cell populations. Relevant cell clusters are indicated. N, neutrophils; MØ, macrophages; E, endothelial cells; F, fibroblasts. ( D ) Flow cytometry analysis of myeloid cells purified from tumors obtained from SuSe mice treated with vehicle or AP21967. We identified TAMs and cells positive for the myeloid marker CD11B and for the macrophage marker F4/80. ( E ) The same cells as in (D) were cultured for 24 hours—in the presence of vehicle or anti-CCL2—and the presence of CCL2 in the conditioned medium was determined by ELISA. ( F ) Schematic representation of the specificities of receptors for CCL2, CCL3, and CCL7. ( G ) Flow cytometry analysis of CCR2 in the same cells as in (D). FSH-H, forward scatter height.
Mcp 1, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ccl2/pm31957197-29-59-60?v=Bioss
Average 94 stars, based on 1 article reviews
mcp 1 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

90
Boster Bio anti mcp 1
( A ) Tumor samples from mice treated with vehicle or AP21967 at 9 weeks were homogenized, and the levels of the indicated cytokines were analyzed using a cytokine array. The log 2 FC (AP21967/vehicle) for each cytokine is presented. ENA-78, epithelial-derived neutrophil-activating peptide 78; GROα, growth-regulated oncogene-alpha. ( B ) Levels of <t>CCL2</t> and CXCL1 were quantified by ELISA from the same tumor homogenates as in (A). ( C ) UMAP plots showing the expression of the most up-regulated cytokines (CCL2, CCL3, and CCL7) and their receptors (CCR1, CCR2, and CCR5) in different cell populations. Relevant cell clusters are indicated. N, neutrophils; MØ, macrophages; E, endothelial cells; F, fibroblasts. ( D ) Flow cytometry analysis of myeloid cells purified from tumors obtained from SuSe mice treated with vehicle or AP21967. We identified TAMs and cells positive for the myeloid marker CD11B and for the macrophage marker F4/80. ( E ) The same cells as in (D) were cultured for 24 hours—in the presence of vehicle or anti-CCL2—and the presence of CCL2 in the conditioned medium was determined by ELISA. ( F ) Schematic representation of the specificities of receptors for CCL2, CCL3, and CCL7. ( G ) Flow cytometry analysis of CCR2 in the same cells as in (D). FSH-H, forward scatter height.
Anti Mcp 1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ccl2/pm37049779-365-30-32?v=Boster+Bio
Average 90 stars, based on 1 article reviews
anti mcp 1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

89
Kingfisher Biotech anti swine ccl2 polyclonal antibody
The effect of porcine notochordal cells (NC)‐derived EVs on pro‐catabolic factors in dog 3D NPC pellets. (A) IL‐6, (B) CXCL8/IL‐8, (C) <t>CCL2,</t> and (D) COX‐2 expression of dog pellets cultured in control medium, medium containing NC‐EVs, and NC‐EV‐depleted media, with and without canine IL‐1β, for 48 h. (E) IL‐6 release in the medium (dl: 15.6 pg), (F) prostaglandin E2 (PGE2) release in the medium (dl: 3.9 pg), and (G) immunohistochemistry for IL‐1β and IL‐1 receptor I (IL‐1RI) of dog pellets cultured for 7 days with corresponding immunopositive surface area (I and J, respectively). Pellets containing a pool of n = 7 dog nucleus pulposus donors were tested with individual porcine NCCM donors ( n = 5, pig 1–5). * p < 0.05, ** p < 0.01. Data are displayed as the grand mean with the individual donors plotted. Detection limit (dl) of the factors is indicated between brackets. The background levels of the EV‐ and EV‐depleted media alone (without pellet culture) were below the detection limit for all measured factors. ND: not detectable. Scale bar indicates 100 μm.
Anti Swine Ccl2 Polyclonal Antibody, supplied by Kingfisher Biotech, used in various techniques. Bioz Stars score: 89/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ccl2/pmc11775941-159-5-13?v=Kingfisher+Biotech
Average 89 stars, based on 1 article reviews
anti swine ccl2 polyclonal antibody - by Bioz Stars, 2026-08
89/100 stars
  Buy from Supplier

91
Kingfisher Biotech anti swine capture antibody
The effect of porcine notochordal cells (NC)‐derived EVs on pro‐catabolic factors in dog 3D NPC pellets. (A) IL‐6, (B) CXCL8/IL‐8, (C) <t>CCL2,</t> and (D) COX‐2 expression of dog pellets cultured in control medium, medium containing NC‐EVs, and NC‐EV‐depleted media, with and without canine IL‐1β, for 48 h. (E) IL‐6 release in the medium (dl: 15.6 pg), (F) prostaglandin E2 (PGE2) release in the medium (dl: 3.9 pg), and (G) immunohistochemistry for IL‐1β and IL‐1 receptor I (IL‐1RI) of dog pellets cultured for 7 days with corresponding immunopositive surface area (I and J, respectively). Pellets containing a pool of n = 7 dog nucleus pulposus donors were tested with individual porcine NCCM donors ( n = 5, pig 1–5). * p < 0.05, ** p < 0.01. Data are displayed as the grand mean with the individual donors plotted. Detection limit (dl) of the factors is indicated between brackets. The background levels of the EV‐ and EV‐depleted media alone (without pellet culture) were below the detection limit for all measured factors. ND: not detectable. Scale bar indicates 100 μm.
Anti Swine Capture Antibody, supplied by Kingfisher Biotech, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+ccl2/pmc11775941-155-11-16?v=Kingfisher+Biotech
Average 91 stars, based on 1 article reviews
anti swine capture antibody - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

Image Search Results


( A ) Tumor samples from mice treated with vehicle or AP21967 at 9 weeks were homogenized, and the levels of the indicated cytokines were analyzed using a cytokine array. The log 2 FC (AP21967/vehicle) for each cytokine is presented. ENA-78, epithelial-derived neutrophil-activating peptide 78; GROα, growth-regulated oncogene-alpha. ( B ) Levels of CCL2 and CXCL1 were quantified by ELISA from the same tumor homogenates as in (A). ( C ) UMAP plots showing the expression of the most up-regulated cytokines (CCL2, CCL3, and CCL7) and their receptors (CCR1, CCR2, and CCR5) in different cell populations. Relevant cell clusters are indicated. N, neutrophils; MØ, macrophages; E, endothelial cells; F, fibroblasts. ( D ) Flow cytometry analysis of myeloid cells purified from tumors obtained from SuSe mice treated with vehicle or AP21967. We identified TAMs and cells positive for the myeloid marker CD11B and for the macrophage marker F4/80. ( E ) The same cells as in (D) were cultured for 24 hours—in the presence of vehicle or anti-CCL2—and the presence of CCL2 in the conditioned medium was determined by ELISA. ( F ) Schematic representation of the specificities of receptors for CCL2, CCL3, and CCL7. ( G ) Flow cytometry analysis of CCR2 in the same cells as in (D). FSH-H, forward scatter height.

Journal: Science Advances

Article Title: Immunosuppressive macrophages determine the effect of cellular senescence on tumor progression

doi: 10.1126/sciadv.adx2988

Figure Lengend Snippet: ( A ) Tumor samples from mice treated with vehicle or AP21967 at 9 weeks were homogenized, and the levels of the indicated cytokines were analyzed using a cytokine array. The log 2 FC (AP21967/vehicle) for each cytokine is presented. ENA-78, epithelial-derived neutrophil-activating peptide 78; GROα, growth-regulated oncogene-alpha. ( B ) Levels of CCL2 and CXCL1 were quantified by ELISA from the same tumor homogenates as in (A). ( C ) UMAP plots showing the expression of the most up-regulated cytokines (CCL2, CCL3, and CCL7) and their receptors (CCR1, CCR2, and CCR5) in different cell populations. Relevant cell clusters are indicated. N, neutrophils; MØ, macrophages; E, endothelial cells; F, fibroblasts. ( D ) Flow cytometry analysis of myeloid cells purified from tumors obtained from SuSe mice treated with vehicle or AP21967. We identified TAMs and cells positive for the myeloid marker CD11B and for the macrophage marker F4/80. ( E ) The same cells as in (D) were cultured for 24 hours—in the presence of vehicle or anti-CCL2—and the presence of CCL2 in the conditioned medium was determined by ELISA. ( F ) Schematic representation of the specificities of receptors for CCL2, CCL3, and CCL7. ( G ) Flow cytometry analysis of CCR2 in the same cells as in (D). FSH-H, forward scatter height.

Article Snippet: For selective CCL2 blocking, 4-week-old PyMT/SuSe mice were treated every 3 days with anti-CCL2 antibody (#BE0185, BioXCell,) at a concentration of 2 μg/g of body weight.

Techniques: Derivative Assay, Enzyme-linked Immunosorbent Assay, Expressing, Flow Cytometry, Purification, Marker, Cell Culture

The effect of porcine notochordal cells (NC)‐derived EVs on pro‐catabolic factors in dog 3D NPC pellets. (A) IL‐6, (B) CXCL8/IL‐8, (C) CCL2, and (D) COX‐2 expression of dog pellets cultured in control medium, medium containing NC‐EVs, and NC‐EV‐depleted media, with and without canine IL‐1β, for 48 h. (E) IL‐6 release in the medium (dl: 15.6 pg), (F) prostaglandin E2 (PGE2) release in the medium (dl: 3.9 pg), and (G) immunohistochemistry for IL‐1β and IL‐1 receptor I (IL‐1RI) of dog pellets cultured for 7 days with corresponding immunopositive surface area (I and J, respectively). Pellets containing a pool of n = 7 dog nucleus pulposus donors were tested with individual porcine NCCM donors ( n = 5, pig 1–5). * p < 0.05, ** p < 0.01. Data are displayed as the grand mean with the individual donors plotted. Detection limit (dl) of the factors is indicated between brackets. The background levels of the EV‐ and EV‐depleted media alone (without pellet culture) were below the detection limit for all measured factors. ND: not detectable. Scale bar indicates 100 μm.

Journal: JOR Spine

Article Title: Explorative Study of Modulatory Effects of Notochordal Cell‐Derived Extracellular Vesicles on the IL ‐1β‐Induced Catabolic Cascade in Nucleus Pulposus Cell Pellets and Explants

doi: 10.1002/jsp2.70043

Figure Lengend Snippet: The effect of porcine notochordal cells (NC)‐derived EVs on pro‐catabolic factors in dog 3D NPC pellets. (A) IL‐6, (B) CXCL8/IL‐8, (C) CCL2, and (D) COX‐2 expression of dog pellets cultured in control medium, medium containing NC‐EVs, and NC‐EV‐depleted media, with and without canine IL‐1β, for 48 h. (E) IL‐6 release in the medium (dl: 15.6 pg), (F) prostaglandin E2 (PGE2) release in the medium (dl: 3.9 pg), and (G) immunohistochemistry for IL‐1β and IL‐1 receptor I (IL‐1RI) of dog pellets cultured for 7 days with corresponding immunopositive surface area (I and J, respectively). Pellets containing a pool of n = 7 dog nucleus pulposus donors were tested with individual porcine NCCM donors ( n = 5, pig 1–5). * p < 0.05, ** p < 0.01. Data are displayed as the grand mean with the individual donors plotted. Detection limit (dl) of the factors is indicated between brackets. The background levels of the EV‐ and EV‐depleted media alone (without pellet culture) were below the detection limit for all measured factors. ND: not detectable. Scale bar indicates 100 μm.

Article Snippet: Detection was performed with biotinylated anti‐swine CCL2 polyclonal antibody (0.1 μg/mL, 60 min, Kingfisher Biotech, PBB0089S‐050), high‐sensitivity streptavidin‐horseradish peroxidase (20 ng/mL, 30 min, Thermo Scientific, 21 134), and 3,3′,5,5′‐tetramethylbenzidine (TMB) substrate (30 min, Thermo Scientific, N301).

Techniques: Derivative Assay, Expressing, Cell Culture, Control, Immunohistochemistry